This report provides a comprehensive analysis of AstraZeneca's strategic management and sustainability initiatives. It begins with an introduction to strategic management and sustainable assessment, followed by a detailed examination of AstraZeneca's key business strategies over the past five years, including their focus on innovation, patient-centricity, and the use of the BCG matrix. The report then delves into the company's resources and capabilities, such as human, physical, financial, intellectual, and social capital, highlighting their role in driving profitability and competitive advantage. The core of the report discusses how AstraZeneca implements sustainability through evidence-based science, theories, and practices, emphasizing their commitment to environmental protection, healthcare access, and ethical conduct. The report concludes with a summary of the findings and references to support the analysis, offering valuable insights into AstraZeneca's approach to strategic management and its commitment to sustainability.